Can You Drink Alcohol With Citalopram?

Drinking alcohol while taking citalopram is strongly discouraged by prescribing guidelines, even though no single drink will trigger an immediate dangerous chemical reaction the way alcohol and certain other drugs can. The risks are subtler but real: amplified sedation, worsened depression, and a compounding effect on a heart-rhythm issue that citalopram can cause on its own. The combination is not as dramatically dangerous as, say, alcohol with opioids, but it works against the medication’s purpose and raises the ceiling on several side effects in ways that can catch people off guard.

Why the Two Do Not Mix Well

Citalopram is a selective serotonin reuptake inhibitor, meaning it increases the amount of serotonin available in the brain. Alcohol, meanwhile, is a central nervous system depressant that also temporarily alters serotonin levels. When you combine the two, the sedative effects of each one can reinforce the other. Drowsiness, dizziness, and impaired coordination all tend to be more pronounced than you would expect from either substance alone. For some people, even one or two drinks on citalopram produces a level of impairment that feels disproportionate to the amount consumed.

Beyond sedation, there is a cognitive dimension. Citalopram can slow reaction times and blur judgment in the first weeks of treatment, before your body adjusts. Alcohol does the same things through different pathways. Layering the two means the period of adjustment to the medication becomes harder to read. You may not be able to tell whether the foggy feeling is a side effect of the drug, the alcohol, or the combination, which makes it difficult to gauge whether the medication is working as intended.

The Heart Rhythm Concern

One of the more serious and underappreciated risks involves the heart. Citalopram is known to prolong a measurement on an electrocardiogram called the QT interval, which reflects how long the heart’s electrical system takes to reset between beats. When the QT interval stretches too far, the heart becomes vulnerable to abnormal rhythms that can, in rare cases, be fatal. This risk led the FDA to cap the recommended maximum dose of citalopram at 40 milligrams per day for most adults and 20 milligrams for people over 60.

Alcohol adds to this picture in a couple of ways. Heavy drinking can independently affect heart rhythm, and alcohol-induced dehydration shifts electrolyte levels, particularly potassium and magnesium, in directions that further extend the QT interval. A case report documented the death of a patient who had been taking citalopram at 60 milligrams per day, a dose above current guidelines, with a post-mortem blood level of 1,300 nanograms per milliliter; the authors concluded that drug-induced QT prolongation combined with another physiological trigger caused lethal heart rhythms.¹ That case involved a supratherapeutic dose and an unusual trigger, not alcohol. But the underlying vulnerability, a heart whose electrical timing has been stretched by citalopram, is present in anyone taking the drug, and adding alcohol’s effects on hydration and electrolytes is not a risk-free proposition.

How Alcohol Works Against the Medication

Citalopram is prescribed to treat depression, anxiety, and related conditions. Alcohol is itself a depressant, and while a drink or two may temporarily lift mood, the net biochemical effect over hours and days is to deepen the symptoms the medication is trying to correct. This is not a theoretical concern. Research on people with both depression and alcohol use problems shows that even when citalopram produces measurable improvements in mood, a substantial share of patients still struggle. One study found that after treatment with citalopram, roughly 36 to 55 percent of participants with co-occurring depression and alcohol use still had severely impaired quality of life and functioning.²

It is also worth noting that the relationship between improved mood and reduced drinking is not as tightly linked as people assume. A controlled pilot study using escitalopram, citalopram’s close pharmacological cousin, found no significant association between changes in depressive symptoms and changes in alcohol use.³ In other words, feeling better on the antidepressant does not automatically translate into drinking less. The two problems, depression and alcohol use, often need to be addressed separately rather than treated as a single issue where fixing one will resolve the other.

Citalopram Can Actually Reduce the Desire to Drink

Here is where the story takes an interesting turn. While the official advice is to avoid alcohol on citalopram, research has found that citalopram itself can reduce how much people want to drink. In a placebo-controlled trial of alcohol-dependent participants, daily alcoholic drinks dropped by about 17.5 percent during citalopram treatment compared with placebo, and the percentage of days spent completely abstinent nearly doubled. Participants also reported decreased interest, desire, craving, and liking for alcohol across the board.⁴

This effect appears to be tied to the serotonin system. People whose serotonin signaling is relatively intact seem to get the most benefit. A study that divided participants by how well their serotonin system responded to a pharmacological probe found a clear split: those with stronger serotonin function significantly cut back on drinking while taking citalopram, while those with more impaired serotonin function saw little benefit and in some cases may have drunk more.⁵ This matters because chronic heavy drinking itself damages serotonin pathways, which means the people most in need of help reducing their intake may be the least likely to experience this particular benefit from citalopram.

Men and Women Respond Differently

The alcohol-reducing effect of citalopram is not uniform across sexes. A study of men and women with alcohol dependence found that men taking citalopram reduced their average drinks per day by 44 percent, while women reduced theirs by 27 percent. The difference was statistically significant even after controlling for baseline depression and anxiety scores.⁶

The reasons for this gap are not fully understood, but biological differences in serotonin metabolism between men and women are a likely factor. Women tend to have different baseline serotonin synthesis rates and receptor distributions, and the interaction between hormonal cycles and serotonin function adds another variable. From a practical standpoint, the takeaway is that citalopram’s ability to dampen alcohol cravings may be more reliable in men than in women, which is useful context for anyone whose doctor is considering citalopram partly with an eye toward co-occurring alcohol concerns.

What About Just One or Two Drinks?

This is the question most people actually have, and the honest answer is that it depends on individual factors in a way that makes blanket reassurance irresponsible. Some people on citalopram report having a glass of wine with dinner and noticing nothing unusual. Others find that even a small amount of alcohol hits them harder than expected, or that they feel notably worse the next morning compared to their pre-medication baseline.

A few things worth knowing if you are weighing this decision:

• Timing matters: Citalopram has a long half-life of roughly 35 hours, so there is no window during the day when the drug is out of your system. Unlike some shorter-acting medications where spacing out doses and drinks can meaningfully reduce overlap, citalopram is always present at meaningful levels once you have been taking it for a few days.
• Early weeks are riskier: Side effects like dizziness and drowsiness peak in the first few weeks of treatment and when doses change. Adding alcohol during this period amplifies the effects at the exact time you are least adapted to the medication.
• Tolerance resets: Many people find that their alcohol tolerance drops on citalopram. Two drinks may feel like four. This is partly because both substances are processed through overlapping liver enzyme pathways, and partly because the combined sedative effect is more than additive.
• Sleep quality suffers: Both citalopram and alcohol independently disrupt sleep architecture. Citalopram tends to suppress REM sleep, while alcohol initially sedates but causes fragmented sleep in the second half of the night. Together, the effect on sleep quality can be pronounced enough to undermine the mood benefits the medication is providing.

None of this means that a single beer at a barbecue will land you in the emergency room. The risks from occasional, light drinking on citalopram are modest for most healthy adults who are on a standard dose. But “modest risk” is not “no risk,” and the risk rises steeply with the amount consumed. Binge drinking on citalopram is genuinely dangerous, both because of the sedation and impairment risk and because of the cumulative strain on heart rhythm.

When the Combination Signals a Bigger Problem

If you find yourself regularly wanting to drink while on citalopram, that itself is worth examining. Depression and alcohol use problems overlap far more than many people realize. About a third of people with major depression also have an alcohol use disorder at some point in their lives, and each condition makes the other harder to treat. Alcohol provides temporary relief from the emotional numbness or agitation that depression produces, which creates a self-reinforcing cycle that the antidepressant alone may not break.

As the research described earlier shows, improvements in depression do not automatically lead to reductions in drinking.³ If both issues are present, the clinical evidence suggests they each need their own treatment strategy. Medications like naltrexone or acamprosate target alcohol cravings through different mechanisms than SSRIs do, and behavioral approaches such as cognitive behavioral therapy have strong track records for both conditions. Relying on citalopram to handle both the depression and the drinking, even given its modest craving-reduction effect, leaves a gap that many patients fall through. That range of 36 to 55 percent who still report severely impaired quality of life after citalopram treatment reflects, at least in part, the difficulty of treating these intertwined conditions with a single medication.²

How Citalopram Compares to Other SSRIs on This Issue

If you are wondering whether switching to a different antidepressant would make alcohol safer, the answer is not really. The sedation-amplifying and depression-worsening effects of alcohol apply to all SSRIs, and the QT prolongation concern, while more pronounced with citalopram, is not absent with other members of the class. Escitalopram, the purified form of citalopram’s active component, carries the same QT warning at lower severity. Sertraline and fluoxetine have somewhat less QT effect but still interact with alcohol in the sedation and mood dimensions.

Where citalopram does stand out is in the craving-reduction research. Most of the controlled studies on SSRIs reducing alcohol desire have been conducted specifically with citalopram. The evidence that it can decrease interest in and consumption of alcohol in certain populations is more robust for citalopram than for other SSRIs, making it something of a double-edged sword: it may help reduce drinking in people who want to cut back, yet carries unique cardiac risks that make the combination of the drug and alcohol more concerning than it would be with, say, sertraline.

For people whose primary concern is managing depression while maintaining an active social life that includes occasional drinking, a conversation with a prescriber about which specific SSRI has the most favorable risk profile given their full health picture, including any cardiac history, electrolyte issues, or other medications that affect the QT interval, is the practical next step. No SSRI makes alcohol safe; the question is which one makes the tradeoff most manageable for a particular person.

Serotonin Syndrome and Alcohol

Serotonin syndrome is a potentially dangerous condition caused by excessive serotonin activity in the brain. It is most commonly triggered by combining two or more serotonin-boosting drugs, such as an SSRI with a triptan migraine medication or certain pain relievers. Alcohol alone, in combination with citalopram, is not a classic trigger for full-blown serotonin syndrome. However, the interaction between alcohol and serotonin pathways is not neutral either. Alcohol acutely increases serotonin release, and in someone already on a medication that prevents serotonin from being cleared away, the temporary spike can produce milder symptoms on the same spectrum: agitation, rapid heart rate, sweating, and muscle twitching. These are uncommon with moderate drinking and far more likely when alcohol is consumed in large quantities or when other serotonin-active substances are in the mix, including some recreational drugs, over-the-counter cough suppressants containing dextromethorphan, and certain herbal supplements like St. John’s wort.

The practical takeaway is not to add serotonin syndrome to your list of everyday worries about a glass of wine, but to recognize that the more substances you combine with citalopram, the less predictable the pharmacological landscape becomes. If you are taking other medications alongside citalopram and plan to drink, the combined serotonin load is a legitimate topic to raise with your pharmacist, who can review the full list for compounding interactions.